Short-term debt is close to the assets that can pay it. Quick ratio 0.75×. 2024 was 0.91×.
Opening company
COMPANY OVERVIEW
Opening company
Org. no. 921 652 690·Aksjeselskap
Ved etablering og opprettholdelse av et laborato- rium å muliggjøre legers klinisk- kjemiske under- søkelser av pasienter, samt hva dertil henhører.
Register details are shown now. Website, social and contact listings fill in as they are found.
firmapost@furst.noBrønnøysundregistrene email
Checking public listings
Company contact from public listings — not a verified direct line to an executive.
Loading annual accounts
Registered group structure from Brønnøysundregistrene. Ownership basis is shown as filed.
Officially registered management, board members and other roles. Each person is looked up by name on 1881 and Gulesider. A number is shown when that listing, Proff or the company website matches this person.
Short-term debt is close to the assets that can pay it. Quick ratio 0.75×. 2024 was 0.91×.
Equity covers a solid share of the balance sheet. 2024 was 35%.
The company earns a healthy operating margin.
Calculated from the annual accounts filed with Brønnøysundregistrene. These bands describe the filed figures. They are not a credit rating. Changes are against the 2024 filing.
Org. no. 921 652 690·Aksjeselskap
Ved etablering og opprettholdelse av et laborato- rium å muliggjøre legers klinisk- kjemiske under- søkelser av pasienter, samt hva dertil henhører.
Company-supplied registry link. Official ownership and availability have not been independently verified.
firmapost@furst.noBrønnøysundregistrene email
Company contact from public listings — not a verified direct line to an executive.
Officially registered management, board members and other roles. Each person is looked up by name on 1881 and Gulesider. A number is shown when that listing, Proff or the company website matches this person.